Matches in Wikidata for { <http://www.wikidata.org/entity/Q77959504> ?p ?o ?g. }
Showing items 1 to 57 of
57
with 100 items per page.
- Q77959504 description "1999 ജനുവരി 1 നു പ്രസിദ്ധീകരിച്ച ശാസ്ത്ര ലേഖനം" @default.
- Q77959504 description "artikull shkencor i botuar më 01 janar 1999" @default.
- Q77959504 description "artículu científicu espublizáu en xineru de 1999" @default.
- Q77959504 description "im Januar 1999 veröffentlichter wissenschaftlicher Artikel" @default.
- Q77959504 description "scientific article published on 01 January 1999" @default.
- Q77959504 description "wetenschappelijk artikel" @default.
- Q77959504 description "наукова стаття, опублікована в січні 1999" @default.
- Q77959504 name "Induction of tyrosinase-reactive T cells by treatment with dacarbazine, cisplatin, interferon-alpha +/- interleukin-2 in patients with metastatic melanoma" @default.
- Q77959504 name "Induction of tyrosinase-reactive T cells by treatment with dacarbazine, cisplatin, interferon-alpha +/- interleukin-2 in patients with metastatic melanoma" @default.
- Q77959504 name "Induction of tyrosinase-reactive T cells by treatment with dacarbazine, cisplatin, interferon-alpha +/- interleukin-2 in patients with metastatic melanoma" @default.
- Q77959504 type Item @default.
- Q77959504 label "Induction of tyrosinase-reactive T cells by treatment with dacarbazine, cisplatin, interferon-alpha +/- interleukin-2 in patients with metastatic melanoma" @default.
- Q77959504 label "Induction of tyrosinase-reactive T cells by treatment with dacarbazine, cisplatin, interferon-alpha +/- interleukin-2 in patients with metastatic melanoma" @default.
- Q77959504 label "Induction of tyrosinase-reactive T cells by treatment with dacarbazine, cisplatin, interferon-alpha +/- interleukin-2 in patients with metastatic melanoma" @default.
- Q77959504 prefLabel "Induction of tyrosinase-reactive T cells by treatment with dacarbazine, cisplatin, interferon-alpha +/- interleukin-2 in patients with metastatic melanoma" @default.
- Q77959504 prefLabel "Induction of tyrosinase-reactive T cells by treatment with dacarbazine, cisplatin, interferon-alpha +/- interleukin-2 in patients with metastatic melanoma" @default.
- Q77959504 prefLabel "Induction of tyrosinase-reactive T cells by treatment with dacarbazine, cisplatin, interferon-alpha +/- interleukin-2 in patients with metastatic melanoma" @default.
- Q77959504 P1104 Q77959504-3A8456E2-6A87-4B98-A155-C7DD156C5B35 @default.
- Q77959504 P1433 Q77959504-8B6B7C8A-9EB7-4DBC-8B98-D7C77B177DF5 @default.
- Q77959504 P1476 Q77959504-139F5473-A099-40D0-9734-DA2FE0A6A1D6 @default.
- Q77959504 P2093 Q77959504-1CEB1785-64BA-4E78-AD1C-BC3F0DCAF8D2 @default.
- Q77959504 P2093 Q77959504-7BB55B44-D858-44DA-85D0-944B82FF0E0F @default.
- Q77959504 P2093 Q77959504-B7039D36-48DE-4032-80E3-2E6D99C2F099 @default.
- Q77959504 P2093 Q77959504-B7C8BAF6-C066-4593-9669-5653998D0885 @default.
- Q77959504 P2093 Q77959504-C61A2157-AF50-403E-A6FE-9CD0121E65DA @default.
- Q77959504 P304 Q77959504-535E018B-ECA6-4F70-B8F2-25A79431CB2C @default.
- Q77959504 P31 Q77959504-F04719B4-BA0F-4917-B3AE-C43A2688F0CF @default.
- Q77959504 P356 Q77959504-F950D0BC-C7A2-4874-B714-37E6196D1AF5 @default.
- Q77959504 P407 Q77959504-13180802-8C52-49C6-9075-E61F7E3D7666 @default.
- Q77959504 P433 Q77959504-ADC64EFC-DAE5-4488-9D76-66D0D201C742 @default.
- Q77959504 P478 Q77959504-A09969E7-B68D-4898-9CF8-A9BC59730B2F @default.
- Q77959504 P577 Q77959504-40436DD6-11F6-4D89-85AD-DC33B9C80825 @default.
- Q77959504 P698 Q77959504-E81B0297-F112-4FA1-AAEC-D9EAEAA40C31 @default.
- Q77959504 P921 Q77959504-1ABEE676-B88A-4531-A942-5824B591FE6B @default.
- Q77959504 P921 Q77959504-3402F2B0-44AB-4CC0-B11F-A5565672C2AD @default.
- Q77959504 P921 Q77959504-F9741189-1952-401B-B032-29ED8256403D @default.
- Q77959504 P356 (SICI)1097-0215(19990105)80:1%3C39::AID-IJC8%3E3.0.CO;2-Y @default.
- Q77959504 P698 9935227 @default.
- Q77959504 P1104 "+5" @default.
- Q77959504 P1433 Q332492 @default.
- Q77959504 P1476 "Induction of tyrosinase-reactive T cells by treatment with dacarbazine, cisplatin, interferon-alpha +/- interleukin-2 in patients with metastatic melanoma" @default.
- Q77959504 P2093 "A Schmittel" @default.
- Q77959504 P2093 "C Scheibenbogen" @default.
- Q77959504 P2093 "E Thiel" @default.
- Q77959504 P2093 "R Max" @default.
- Q77959504 P2093 "U Keilholz" @default.
- Q77959504 P304 "39-43" @default.
- Q77959504 P31 Q13442814 @default.
- Q77959504 P356 "10.1002/(SICI)1097-0215(19990105)80:1<39::AID-IJC8>3.0.CO;2-Y" @default.
- Q77959504 P407 Q1860 @default.
- Q77959504 P433 "1" @default.
- Q77959504 P478 "80" @default.
- Q77959504 P577 "1999-01-01T00:00:00Z" @default.
- Q77959504 P698 "9935227" @default.
- Q77959504 P921 Q18975855 @default.
- Q77959504 P921 Q412415 @default.
- Q77959504 P921 Q416975 @default.